66 related articles for article (PubMed ID: 24704988)
1. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
Volz Y; Trappmann R; Ebner B; Eismann L; Enzinger B; Hermans J; Pyrgidis N; Stief C; Schulz GB
Urol Int; 2024; 108(1):42-48. PubMed ID: 37944501
[TBL] [Abstract][Full Text] [Related]
2. MRI for risk stratification of muscle invasion by upper tract urothelial carcinoma: a feasibility study.
Messina E; Proietti F; Laschena L; Flammia RS; Pecoraro M; Cipollari S; Simone G; Catalano C; Leonardo C; Panebianco V
Eur Radiol Exp; 2024 Jan; 8(1):9. PubMed ID: 38238523
[TBL] [Abstract][Full Text] [Related]
3. Tumour seeding as a result of intraperitoneal perforation during transurethral resection of non-muscle invasive bladder cancer.
Cusano A; Murphy G; Haddock P; Wagner J
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25253487
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma.
Strope AM; Phillips C; Khadgi S; Jenkinson SA; Coschigano KT; Malgor R
Histol Histopathol; 2024 Jun; 39(6):715-727. PubMed ID: 38445662
[TBL] [Abstract][Full Text] [Related]
5. Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link.
Chamie K; Ballon-Landa E; Bassett JC; Daskivich TJ; Leventhal M; Deapen D; Litwin MS
Cancer; 2015 Feb; 121(3):379-85. PubMed ID: 25339141
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Novel Technique of Flexible Cystoscopic En Bloc Snare Resection of Bladder Tumor: f-ESRBT.
Matsukawa A; Kimura S; Koike Y; Ajisaka S; Aikawa K; Obayashi K; Yanagisawa T; Kimura T; Miki J
J Endourol; 2023 Jun; 37(6):713-717. PubMed ID: 36987377
[No Abstract] [Full Text] [Related]
7. Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma.
Zhang HP; Liang RX; Lin XY; Xue ES; Ye Q; Zhu YF
BMC Med Imaging; 2024 Jan; 24(1):26. PubMed ID: 38273224
[TBL] [Abstract][Full Text] [Related]
8. Effects of delayed diagnosis on tumor size, stage and grade in bladder cancer.
Gercek O; Ulusoy K; Yazar VM; Topal K
Int Urol Nephrol; 2024 Mar; 56(3):935-940. PubMed ID: 37847325
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in three-dimensional ultrasound virtual cystoscopy in modeling and local staging for urothelial carcinoma with histopathological correlation: a cohort prospective study.
Mohamed HI; Aly M; Badran Y; Fawzy M; El-Damanhory H; Gomma A; Ghoneimy OM; Abdelaleem MF; Elsharkawy M; Fayad S; Zidan AM; Soltan HA; Samih TAA; Aboelsaad AY; Abdel Gawad AM; Moustafa BA; Abbas H; Aly NM; Elhawary R; Hasan A
Ann Med Surg (Lond); 2023 Nov; 85(11):5365-5371. PubMed ID: 37915685
[TBL] [Abstract][Full Text] [Related]
10. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?
Bryan RT; Catto JWF; Jefferson KP; Patel P; James ND; On Behalf Of The BladderPath Trial Management Group
Eur Urol; 2021 Jul; 80(1):18-19. PubMed ID: 33972095
[No Abstract] [Full Text] [Related]
11. Urinoids - a new tool to study bladder cancer.
Masone MC
Nat Rev Urol; 2024 Feb; 21(2):63. PubMed ID: 38228739
[No Abstract] [Full Text] [Related]
12. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran.
Payandeh M; Sadeghi M; Sadeghi E
Iran J Cancer Prev; 2015 Dec; 8(6):e4038. PubMed ID: 26855723
[TBL] [Abstract][Full Text] [Related]
13. Preoperative imaging for staging bladder cancer.
McKibben MJ; Woods ME
Curr Urol Rep; 2015 Apr; 16(4):22. PubMed ID: 25724433
[TBL] [Abstract][Full Text] [Related]
14. A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging.
Xu C; Zhang Z; Wang H; Song Q; Wei R; Yu Y; Li J; Sun Y
PLoS One; 2014; 9(4):e92385. PubMed ID: 24704988
[TBL] [Abstract][Full Text] [Related]
15. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
16. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
[TBL] [Abstract][Full Text] [Related]
17. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
[TBL] [Abstract][Full Text] [Related]
19. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
